Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics

…, N Sharpe, M Mullen, WS Meschino - American journal of …, 2001 - Wiley Online Library
… Ethics and the law are clear that patients have the right to be informed when a mistake
has been made, and this duty 皋ws from the original relationship. …

Hereditary breast and ovarian cancers

…, J Grimshaw, C Honeywell, WS Meschino… - Canadian Family …, 2008 - cfp.ca
… Dr Meschino is a Clinical Geneticist at North York General Hospital and Assistant Professor
in the Department of Paediatrics at the University of Toronto. Ms Permaul is a Research …

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap

…, K Kieser, A MacMillan, WS Meschino… - Journal of medical …, 2018 - jmg.bmj.com
The landscape of genetic testing in ovarian cancer patients has changed dramatically in
recent years. The therapeutic benefits of poly ADP-ribose polymerase (PARP) inhibitors in …

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

…, G DeBoer, MJ Yaffe, SJ Messner, WS Meschino… - Jama, 2004 - jamanetwork.com
ContextCurrent recommendations for women who have a BRCA1 or BRCA2 mutation are to
undergo breast surveillance from age 25 years onward with mammography annually and …

De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

…, JL Lauzon, AE Lin, GMS Mancini, WS Meschino… - Nature …, 2012 - nature.com
Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus
(MPPH) syndromes are sporadic overgrowth disorders associated …

[HTML][HTML] Phenotypic heterogeneity of genomic disorders and rare copy-number variants

…, JS McConnell, B Angle, WS Meschino… - … England Journal of …, 2012 - Mass Medical Soc
Background Some copy-number variants are associated with genomic disorders with
extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents …

Molecular mechanism for duplication 17p11. 2—the homologous recombination reciprocal of the Smith-Magenis microdeletion

…, MA Withers, V Kimonis, AM Summers, WS Meschino… - Nature …, 2000 - nature.com
Recombination between repeated sequences at various loci of the human genome are known
to give rise to DNA rearrangements associated with many genetic disorders 1. Perhaps …

[HTML][HTML] International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

…, L Senter, S Armel, L Bordeleau, WS Meschino… - British journal of …, 2019 - nature.com
Background Women with a BRCA1 or BRCA2 mutation face high risks of breast and ovarian
cancer. In the current study, we report on uptake of cancer screening and risk-reduction …

[PDF][PDF] Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening …

…, M Horgan, JC Carroll, A Eisen, WS Meschino… - J Clin …, 2014 - cancercareontario.ca
Purpose The Ontario Breast Screening Program expanded in July 2011 to screen women
age 30 to 69 years at high risk for breast cancer with annual magnetic resonance imaging (MRI…

[HTML][HTML] Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 …

…, R Salim, T Huang, A Adank, J Zhang, WS Meschino… - The Lancet, 2022 - thelancet.com
Background Existing evidence on the effects of race and ethnicity on pregnancy outcomes is
restricted to individual studies done within specific countries and health systems. We aimed …